Sort
17,828 grants matching “crispr”
Analysis of chemical modulators for corneal endothelial dystrophies
$403,750Matilda F Chan · University Of California, San Francisco · R01 · FY2024 · EY
A novel progenitor population in pancreatic endocrine cell development
$403,750Julie Beth Sneddon · University Of California, San Francisco · R01 · FY2023 · DK
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression
$403,750Luke Gilbert · University Of California, San Francisco · R01 · FY2021 · HG
Understanding the mechanisms that regulate cytoplasmic capping and defining its contributions to post-transcriptional gene regulation
$403,750Daniel Louis Kiss · Methodist Hospital Research Institute · R35 · FY2021 · GM
A novel progenitor population in pancreatic endocrine cell development
$403,750Julie Beth Sneddon · University Of California, San Francisco · R01 · FY2021 · DK
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
$403,750Deepak Ashok Lamba · University Of California, San Francisco · R01 · FY2021 · EY
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
$403,750Erik M Ullian · University Of California, San Francisco · R01 · FY2025 · EY
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2022 · NS
A novel progenitor population in pancreatic endocrine cell development
$403,750Julie Beth Sneddon · University Of California, San Francisco · R01 · FY2022 · DK
Establishing the feasibility of editing the human gut microbiome
$403,750Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2021 · AT
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression
$403,750Hani Goodarzi · University Of California, San Francisco · R01 · FY2022 · HG
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$403,750Manish Aghi · University Of California, San Francisco · R01 · FY2023 · NS
Analysis of chemical modulators for corneal endothelial dystrophies
$403,750Matilda F Chan · University Of California, San Francisco · R01 · FY2021 · EY
Analysis of chemical modulators for corneal endothelial dystrophies
$403,750Matilda F Chan · University Of California, San Francisco · R01 · FY2025 · EY
Targeting epigenetic abnormalities to inhibit cutaneous squamous cell carcinoma
$403,744Masaoki Kawasumi · University Of Washington · R01 · FY2022 · CA
Identification of pathogenic mechanisms important in multiple system atrophy
$403,647Matt Huentelman · Translational Genomics Research Inst · R21 · FY2015 · NS
Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma
$403,643G Greg Wang · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Manipulation of Sox9-positive osteochondroprogenitor cells towards cell-based gene therapy for genetic bone diseases.
$403,291Tatsuya Kobayashi · Massachusetts General Hospital · R61 · FY2019 · AR
Setting the Stage for Replacement of Mitochondrial Genes
$403,232Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2021 · EY
Setting the Stage for Replacement of Mitochondrial Genes
$403,232Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2024 · EY
Setting the Stage for Replacement of Mitochondrial Genes
$403,232Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2025 · EY
Setting the Stage for Replacement of Mitochondrial Genes
$403,232Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2023 · EY
tRNA-fragments in transposon control
$403,200Andrea Schorn · Cold Spring Harbor Laboratory · R01 · FY2024 · GM
tRNA-fragments in transposon control
$403,200Andrea Schorn · Cold Spring Harbor Laboratory · R01 · FY2021 · GM
tRNA-fragments in transposon control
$403,200Andrea Schorn · Cold Spring Harbor Laboratory · R01 · FY2022 · GM